Approvals/TGA/ABILIFY ASIMTUFII aripiprazole (as monohydrate) 960 mg/3.2 mL prolonged release suspension for injection pre-filled syringe

Approved

STANDARD

ABILIFY ASIMTUFII aripiprazole (as monohydrate) 960 mg/3.2 mL prolonged release suspension for injection pre-filled syringe

Lundbeck Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 59a7e1b5705cbf26
Product Name: ABILIFY ASIMTUFII aripiprazole (as monohydrate) 960 mg/3.2 mL prolonged release suspension for injection pre-filled syringe
Artg Id: 410039
Artg Name: ABILIFY ASIMTUFII aripiprazole (as monohydrate) 960 mg/3.2 mL prolonged release suspension for injection pre-filled syringe
Sponsor: Lundbeck Australia Pty Ltd
Company Detail Path: /organization/lundbeck-australia-pty-ltd
Artg Date: 2025-02-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f713fc4797af46ed05e44992e472de3e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a93227e3848ab3ab9758837c58bbfd47.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

59a7e1b5705cbf26

Type

Standard